Insider filing · NTRA

Roelof Botha sold $17.7M of Natera (NTRA)

Executed Nov 24 2025, disclosed Nov 26 2025, 2 days later.

Returns are measured on stock purchases only.

RB Roelof Botha Director profile →

Roelof Botha (Director) filed 5 Form 4 reports in the trailing twelve months (1 purchase, 4 sales), most often in Natera, Inc. (NTRA). Across 1 priced purchase filing, the average 21-session return was -35.0% from execution and -15.9% from disclosure (delay-adjusted; derived). The largest single filing was $17.7M of NTRA (75,000 sh across 11 lots, as filed), executed Nov 24 2025.

NTRA Natera, Inc. NTRA · Healthcare · 219 filings in 24 months ticker →

Healthcare · Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→